Literature DB >> 8938158

Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids.

C Tibbs1, P Donaldson, J Underhill, L Thomson, K Manabe, R Williams.   

Abstract

In the search for factors which may influence susceptibility to and outcome from chronic hepatitis C virus (HCV) infection, few studies have considered the influence of host genes. In the present investigation we have performed HLA DRB1, DQA1, DQB1, and DPB1 genotyping on 104 northern European patients with chronic HCV infection and 177 racially and geographically matched controls. Three HLA class II alleles, DRB1*0403, DQA1*03, and DQB1*0302 were present at a significantly lower frequency in patients compared with controls (4.9% vs. 13%, 20.7% vs. 41.2%, and 11.4% vs. 30.5%, respectively) though only two DQB1*0302 and DQA1*03 were significant after correction for multiple testing (pc = 0.038, and pc = 0.046, respectively). No further HLA associations with chronic HCV infection were observed and there was no correlation between stage of disease and HLA genotype. These data provide the first suggestion that susceptibility to chronic HCV infection may be influenced by the hosts' HLA DQ alleles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8938158     DOI: 10.1053/jhep.1996.v24.pm0008938158

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: a meta-analysis.

Authors:  Xin Hong; Rong-Bin Yu; Nan-Xiong Sun; Bin Wang; Yao-Chu Xu; Guan-Ling Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease.

Authors:  H L Tillmann; D F Chen; C Trautwein; V Kliem; A Grundey; A Berning-Haag; K Böker; S Kubicka; L Pastucha; W Stangel; M P Manns
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

4.  Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection.

Authors:  Ayla Yenigün; Belma Durupinar
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Analysis of two susceptibility SNPs in HLA region and evidence of interaction between rs6457617 in HLA-DQB1 and HLA-DRB1*04 locus on Tunisian rheumatoid arthritis.

Authors:  Yosser Achour; Mariem Ben Hamad; Souhir Chaabane; Ahmed Rebai; Sameh Marzouk; Nadia Mahfoudh; Zouhir Bahloul; Leila Keskes; Abdellatif Maalej
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

6.  Curative effects of interferon-alpha and HLA-DRB1 -DQA1 and -DQB1 alleles in chronic viral hepatitis B.

Authors:  Guo-Qing Zang; Min Xi; Ming-Liang Feng; Yun Ji; Yong-Sheng Yu; Zheng-Hao Tang
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

Review 7.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

8.  A large-scale investigation into the role of classical HLA loci in multiple types of severe infections, with a focus on overlaps with autoimmune and mental disorders.

Authors:  Ron Nudel; Rosa Lundbye Allesøe; Wesley K Thompson; Thomas Werge; Simon Rasmussen; Michael E Benros
Journal:  J Transl Med       Date:  2021-05-31       Impact factor: 5.531

9.  Role of host genetic factors in the outcome of hepatitis C virus infection.

Authors:  Bertram Bengsch; Robert Thimme; Hubert E Blum
Journal:  Viruses       Date:  2009-08-05       Impact factor: 5.818

10.  Replication of british rheumatoid arthritis susceptibility Loci in two unrelated chinese population groups.

Authors:  Hua Li; Yonghe Hu; Tao Zhang; Yang Liu; Yantang Wang; Tai Yang; Minhui Li; Qiaoli Luo; Yu Cheng; Qiang Zou
Journal:  Clin Dev Immunol       Date:  2013-09-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.